All Updates

All Updates

icon
Filter
Partnerships
Product updates
Google DeepMind and Isomorphic Labs unveil updated AlphaFold technology
AI Drug Discovery
May 8, 2024
This week:
Funding
GrayMatter Robotics raises USD 45 million in Series B funding to accelerate AI-powered robotics solutions
Smart Factory
Yesterday
Funding
Vecna Robotics raises USD 100 million in Series C funding; appoints new COO
Logistics Tech
Yesterday
Funding
Vecna Robotics raises USD 100 million in Series C funding; appoints new COO
Smart Factory
Yesterday
Funding
FairNow raises USD 3.5 million to advance AI governance solutions
Generative AI Infrastructure
Yesterday
Partnerships
Gravitics develops testing gauntlet for larger spacecraft in collaboration with NASA
Space Travel and Exploration Tech
Yesterday
M&A
knownwell acquires Alfie Health to integrate AI in primary and obesity care services
Telehealth
Yesterday
Funding
Pomelo Care raises USD 46 million in Series B funding to expand virtual maternal care
Telehealth
Yesterday
Funding
Isar Aerospace raises EUR 65 million, backed by NATO Innovation Fund
Space Travel and Exploration Tech
Yesterday
Product updates
Beyond Meat releases new Beyond Sausage, expanding its Beyond IV product line
Plant-based Meat
Yesterday
Product updates
Funding
SurrealDB raises USD 20 million in Series A; launches beta version of Surreal Cloud
Data Infrastructure & Analytics
Yesterday
AI Drug Discovery

AI Drug Discovery

May 8, 2024

Google DeepMind and Isomorphic Labs unveil updated AlphaFold technology

Partnerships
Product updates

  • Google DeepMind, together with Isomorphic Labs, has introduced a new version of its AlphaFold AI technology, which helps scientists understand the behavior of the microscopic mechanisms that drive the cells in the human body. Launched in 2018, the earlier version of AlphaFold was released in 2023 for protein study.

  • AlphaFold's primary function is to study the twisting and folding process of proteins and their interaction with other human cells. The new version, AlphaFold3, is reported to have the additional feature of predicting the behavior of other microscopic biological mechanisms, including DNA and RNA.

  • Isomorphic Labs, a subsidiary of Alphabet, is a UK-based company that aims to enhance the traditional drug discovery process through the application of AI. The company is currently building on Google DeepMind’s AI research and collaborating with pharmaceutical companies, including Eli Lilly and Novartis, to advance its AI-driven drug discovery efforts.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.